DoD Gulf War Illness Clinical Partnership Award | Apply Online

Opportunity Summary:

The DoD Gulf War Illness Research Program (GWIRP) Clinical Partnership Award (CPA) is a FY16 funding mechanism created to speed up progress in Gulf War Illness (GWI) diagnosis and treatment by deliberately pairing clinical and laboratory expertise in a way that is difficult to accomplish through a single investigator or single institution acting alone. The central idea is to move promising findings toward real-world clinical usefulness for Veterans with GWI, while also allowing clinical observations to loop back and shape biomarker discovery and pathophysiology research. In practice, the program is looking for projects that actively connect "bench and bedside" so that hypotheses can be generated from lab discoveries, population studies, or day-to-day clinical experience, and then refined through a reciprocal exchange of data, samples, and interpretation across the partnership.

A defining feature of this opportunity is the required multi-institutional, multidisciplinary team structure. Applications must be built around a partnership of two or three investigators: one Initiating Principal Investigator and one or two Partnering PIs. Each PI receives a separate award, but the work is meant to be tightly integrated, with all partners providing substantial intellectual leadership. The solicitation is explicit that a partnership does not meet the program intent if the clinician is simply providing access to patients or tissue samples without meaningful involvement in study design, interpretation, and the overall translational strategy. At minimum, the partnership must include at least one laboratory scientist and at least one clinician, where "clinician" means a properly credentialed care provider (with the necessary degrees, licenses, and certifications) at the institution of record. The team also has to demonstrate that it has, or can credibly access, a suitable and sufficient clinical care population of GWI patients to support the proposed work. Additionally, at least one partner must bring significant prior experience in GWI research, and applicants are expected to document credentials clearly in biographical sketches.

In terms of the science, the award is focused on research that informs and advances clinical practice rather than simply running standard treatment tests in a generic translational model. The opportunity encourages work such as tailoring or individualizing treatment approaches, exploring potential therapeutic options in a careful and clinically grounded way, and using clinical case series or other clinically derived datasets to inform biomarker development or deeper understanding of GWI biology. The solicitation frames translational research as a two-way continuum, meaning the strongest projects will show how lab insights guide clinical investigation and how clinical findings, including heterogeneity in patient presentation and response, feed back into mechanistic hypotheses, target identification, and future study design. The announcement even points applicants to a well-known translational research "developmental pathways" framework (originally created for cancer research) as a planning tool, emphasizing that the program values a clearly articulated pathway from discovery through steps that position the field for eventual clinical implementation.

This mechanism is not intended to fund full clinical trials. The program draws a clear line: a clinical trial, as defined here, involves prospective accrual of patients where an intervention (such as a drug, device, biologic, procedure, rehabilitation, or behavioral approach) is tested in humans for measurable outcomes related to safety, effectiveness, or efficacy. Instead of supporting that kind of trial, the Clinical Partnership Award may support correlative studies tied to an existing clinical trial, research that improves or optimizes the design of future trials, and limited exploratory clinical testing when the purpose is feasibility assessment or refinement of a device or intervention. Applicants who want to run a clinical trial are directed to use the FY16 GWIRP Treatment Evaluation Award mechanism rather than the CPA. The announcement also references additional human-subject guidance materials for distinguishing clinical trials from other forms of clinical research, signaling that applicants should be careful and precise in describing human-subject activities and regulatory implications.

From an administrative standpoint, the opportunity was issued by DOD-AMRAA under Funding Opportunity Number W81XWH-16-GWIRP-CPA, categorized as discretionary and offered via cooperative agreement and grant instruments under CFDA 12.420. Eligibility is described as unrestricted (open broadly to applicant entities, subject to any clarifications in the full text). The original and current closing date listed is October 20, 2016, with an expected two awards. The award ceiling is listed as 0 in the source record, which typically means the ceiling was not specified in that particular database field rather than implying no limit, so applicants would normally confirm budget limits in the full program announcement materials. Overall, the CPA is best understood as a team-science translational mechanism aimed at producing clinically meaningful, near-term advances for Veterans with GWI by forcing genuine collaboration between clinical care settings and research laboratories, while keeping the scope short of full-scale interventional clinical trials.

Browse more opportunities from the same agency: DOD-AMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Gulf War Illness Treatment Evaluation Award

Previous opportunity: AFRI Sustainable Bioenergy and Bioproducts RFA

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 16 GWIRP CPA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 16 GWIRP CPA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 16 GWIRP CPA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.